PubMed Health⌕ Search

Biomedical subjects

A W Osiason

Publications and source records attributed to A W Osiason.

3 recordsLinked to original sources

Reperfusion edema after thromboendarterectomy: radiographic patterns of disease.

In patients with chronic pulmonary embolism, pulmonary thromboendarterectomy may result in a unique form of noncardiogenic pulmonary edema termed reperfusion edema. This report reviews the authors' experience after pulmonary thromboendarterectomy with particular emphasis on the radiographic manifestations of reperfusion edema. The clinical and radiographic record of 25 patients who underwent pulmonary thromboendarterectomy at the University of Pennsylvania from 1985 through 1995 were reviewed. The zonal distribution of radiographic opacity, time to maximal opacity, and the time to clearance of reperfusion edema were determined. The relationship of these radiographic manifestations to clinical severity of disease and clinical outcome was examined. Reperfusion edema, characterized by patchy bilateral perihilar alveolar opacities, occurred in all but one patient. There is a lower lung zone predominance of opacities, but in individual cases, striking unilateral or haphazard arrangements of opacities may be seen. In this small sample of patients, no association between preoperative pulmonary arterial pressures and radiographic appearance or clinical outcome was found. However, severity of radiographic opacities, as measured by the extent of involved lung, correlated with disease severity, as measured by time to extubation and time to discharge. Pneumonia, defined as a radiographic opacity that evolves discordantly with the reperfusion edema opacities, occurred in 20% of cases. Reperfusion edema is a common consequence of pulmonary thromboendarterectomy. The severity of radiographic manifestations and clinical severity of disease are related. This characteristically appears as perihilar alveolar opacities.

Adult↗

Pulmonary MR angiography.

Recent technical improvements have made pulmonary MR angiography (MRA) feasible. The technique is attractive because it is noninvasive, provides a full three-dimensional (3D) display of the pulmonary vasculature, and potentially can be combined with MR venography of the lower extremities and pelvis for the comprehensive diagnosis of thromboembolism. Approaches to acquiring pulmonary MR angiograms are currently being developed and include both two-dimensional and 3D time-of-flight methods, breath-hold and non-breath-hold techniques, and the use of gadolinium-based contrast enhancement. The results of initial studies using pulmonary MRA for the detection of pulmonary embolism are encouraging, but they must be evaluated in conjunction with newly developed fast CT scanning techniques. This article reviews the state of development of pulmonary MRA, the current clinical applications of the technique, and the prospects for future development.

Humans↗

Curative, platinum-based cytoxic drug therapy in a renal transplant recipient with metastatic testicular cancer.

Since June 1979, the authors have had the opportunity to treat a renal homograph recipient who developed primary embryonal cell testicular carcinoma with retroperitoneal and pulmonary metastases. This patient was treated with an induction chemotherapy protocol of vinblastine sulfate, bleomycin, and cisplatin and has remained free of disease through June 1985, without loss of his renal homograph. Cisplatin-based cytoxic drug therapy can be delivered safely to a renal transplant recipient without causing kidney damage, and, in this case, achieved a cure of metastatic testicular cancer.

Adult↗